Literature DB >> 12223512

Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion.

Christian Kupatt1, Reinhard Wichels, Jan Horstkotte, Fritz Krombach, Helmut Habazettl, Peter Boekstegers.   

Abstract

Leukocyte interaction with platelets and endothelial cells as cause of myocardial stunning was investigated. Mice were anesthetized and, after thoracotomy, the LAD was ligated for 20 min. Where indicated, rhodamine 6G for leukocyte labeling, fluorescence-labeled platelets, and the GPIIb/IIIa antagonist Tirofiban were infused at the onset of reperfusion in vivo. After 15 min, hearts were quickly excised and analyzed by fluorescence microscopy or assessed for left ventricular developed pressure (LVDP). After in vivo ischemia and reperfusion, leukocyte retention in the heart was 55 +/- 5/field in wild-type hearts, 38 +/- 3/field in P-selectin-/- hearts, and 23 +/- 4/field in P-selectin/intercellular adhesion molecule-1 (ICAM-1)-/- hearts. Postischemic LVDP (48+/-4 mmHg in wild-type hearts) improved in P-selectin-/- and P-selectin/ICAM-1-/- hearts (58+/-4 and 79+/-6 mmHg). Tirofiban reduced platelet adhesion (23+/-4/field vs. 61+/-2/field in wild-type hearts) and leukocyte recruitment (34+/-2/field), improving LVDP (63+/-4 mmHg). Whereas wild-type platelets displayed similar adherence to P-selectin/ICAM-1-/- hearts as platelets from the same genetic strain (63+/-3 vs. 61+/-4 platelets/field), wild-type platelet infusion restored postischemic leukocyte recruitment in P-selectin/ICAM-1-/- hearts (55+/-4/field vs. 23+/-4/field), an effect sensitive to Tirofiban inhibition (23+/-4 leukocytes/field, 22+/-3 platelets/field). We conclude that platelets contribute postischemic leukocyte adhesion in the heart via P-selectin and GPIIb/IIIa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223512

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

Review 1.  Platelets: a critical link between inflammation and microvascular dysfunction.

Authors:  Karen Y Stokes; D Neil Granger
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

Review 2.  Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies.

Authors:  Kathryn E Webert; Christine M Cserti; Judy Hannon; Yulia Lin; Katerina Pavenski; Jacob M Pendergrast; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2008-01

3.  Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome.

Authors:  Budi Y Setianto; Anggoro B Hartopo; Putrika P R Gharini; Dyah W Anggrahini; Bambang Irawan
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

4.  Platelets, acting in part via P-selectin, mediate cytomegalovirus-induced microvascular dysfunction.

Authors:  Mikhail V Khoretonenko; Jerry L Brunson; Evgeny Senchenkov; Igor L Leskov; Christian R Marks; Karen Y Stokes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-17       Impact factor: 4.733

5.  Atorvastatin at reperfusion reduces myocardial infarct size in mice by activating eNOS in bone marrow-derived cells.

Authors:  Yikui Tian; Joel Linden; Brent A French; Zequan Yang
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

Review 6.  The role of platelets in the recruitment of leukocytes during vascular disease.

Authors:  G Ed Rainger; Myriam Chimen; Matthew J Harrison; Clara M Yates; Paul Harrison; Stephen P Watson; Marie Lordkipanidzé; Gerard B Nash
Journal:  Platelets       Date:  2015-07-21       Impact factor: 3.862

Review 7.  Platelet Contributions to Myocardial Ischemia/Reperfusion Injury.

Authors:  Nancy Schanze; Christoph Bode; Daniel Duerschmied
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

Review 8.  Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target.

Authors:  Melanie Ziegler; Xiaowei Wang; Karlheinz Peter
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

9.  Platelets differentially modulate CD4+ Treg activation via GPIIa/IIIb-, fibrinogen-, and PAR4-dependent pathways.

Authors:  Matthias Bock; Christian B Bergmann; Sonja Jung; Peter Biberthaler; Laura Heimann; Marc Hanschen
Journal:  Immunol Res       Date:  2021-12-21       Impact factor: 2.829

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.